This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We recently reported a study¹ of the effects of sumatriptan succinate on workplace productivity during a migraine attack, where treatment with subcutaneous sumatriptan reduced migraine-associated productivity loss by approximately 50% compared with placebo. To examine the annual labor costs associated with the differences observed in workplace productivity losses, we have completed a post hoc cost analysis of these data.

Annual labor costs were calculated using the following formula: labor cost = productivity loss in hours per attack x mean hourly wage x 3 workplace attacks per month x 12 months. Productivity loss represents the total number of hours lost from work owing to symptoms as well as hours lost owing to reduced effectiveness while working with symptoms. Mean wage per hour was determined by occupational category using national labor statistics.² The average of 3 workplace migraines per month was based on data from similar migraine populations in long-term multiple-attack clinical . . . [Full Text of this Article]

RELATED ARTICLE

Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack: Results of a Double-blind, Placebo-Controlled Trial
Roger C. Cady, Robert Ryan, Priti Jhingran, Stephen O'Quinn, and D. Gayla Pait
Arch Intern Med. 1998;158(9):1013-1018.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patterns of health care utilization for migraine in England and in the United States
Lipton et al.
Neurology 2003;60:441-448.
ABSTRACT | FULL TEXT